Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase.
Forty-eight patients treated by allogeneic bone marrow transplantation (BMT) for Philadelphia (Ph) chromosome-positive chronic myeloid leukemia in chronic phase had serial cytogenetic studies of marrow performed at intervals after transplant. Twenty patients received marrow cells from donors of opposite sex. Ph+ marrow metaphases were identified in 24 of 48 (50%) of patients after BMT; they were first seen early (within 1 year) in 16 cases and late (greater than 1 year after BMT) in eight cases. Ph-positivity after BMT occurred more commonly in recipients of T-depleted than nondepleted marrow (19 of 28 v 5 of 20). In 4 cases the Ph+ metaphases were found only transiently after BMT; in 11 cases the Ph+ metaphases have persisted but hematologic relapse has not ensued; in 9 cases the finding of Ph+ metaphases coincided with or preceded hematologic relapse. Chromosomes in cells of donor origin had morphological abnormalities in two cases. No relapses were identified in cells of donor origin. Our data suggest that the relationship between cells of recipient and donor origin is complex: cure of leukemia may depend on factors that operate for some months or years after BMT.
Arthur
C K
CK
Medical Research Council Leukaemia Unit, Hammersmith Hospital, London.
Apperley
J F
JF
Guo
A P
AP
Rassool
F
F
Gao
L M
LM
Goldman
J M
JM
D016026:Bone Marrow Transplantation; D002869:Chromosome Aberrations; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D008212:Lymphocyte Depletion; D008297:Male; D010677:Philadelphia Chromosome